Author: Fatima Jabri

Zahrawi Group was pleased to participate in the Emirates Digestive Diseases Conference 2025 (EDDW 2025), held at the Mövenpick Grand Al Bustan Dubai, UAE.

The conference, recognized as one of the Middle East’s top platforms in gastroenterology and endoscopy, brought together leading experts, doctors, and researchers to exchange insights, showcase innovations, and participate in hands-on training on the latest advancements in digestive diseases and endoscopic technologies.

As part of our ongoing commitment to supporting the medical community, our Medical Team showcased a range of innovative solutions from our valued partners. This included Medifactia’s Transit-Pellets Radiopaque Marker, a safe and effective method for the quantitative evaluation of overall and regional colonic transit.

Additionally, our they had the opportunity to showcase the SonoTip EUS Needle from our partner Medi-Globe, designed to enhance precision and safety in endoscopic ultrasound procedures.

The Medical Team also presented the High Resolution Manometry system from our partner Laborie — a cutting-edge diagnostic tool traditionally used in gastroenterology to assess esophageal motility disorders.

It was a great opportunity for Zahrawi Group to connect with experts in the field and showcase how our solutions can support better outcomes in gastroenterology and endoscopy.

Zahrawi Group proudly joined the 5th Emirates international Annual Conference of Nuclear Medicine & Molecular imaging, held at Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.

The event featured insightful discussions, best practice exchanges, and in-depth reviews of advanced imaging and therapeutic procedures, all aligned with the latest and most practical guidelines and protocols.

Our Medical Division showcased a range of innovative solutions from our esteemed partner, LemerPax. A key highlight was the POSIJET system — an advanced, independent fractionation and injection unit designed for the precise diagnostic and therapeutic administration of high-energy radiopharmaceuticals.

Zahrawi Group’s presence at the conference underscored our commitment to advancing the field of Nuclear Medicine and fostering global collaboration.